Editorial Board  by unknown
Volume 1832, Issue 1, January 2013
ABB
Biochimica et Biophysica Acta
MOLECULAR BASIS OF DISEASE
Executive Editors:  Jeffrey N. Keller (Baton Rouge, LA, USA)
Ronald P. Oude Elferink (Amsterdam, 
     The Netherlands)
Section Editors:
Allan Butterfield (Lexington, KY, USA)
Angus G. Dalgleish (London, UK)
Rafael de Cabo (Baltimore, MD, USA)
Jason R.B. Dyck (Edmonton, Alberta,     
Canada)
Robert J. Ferrante (Pittsburgh, PA, USA)
Marten Hofker (Groningen, Netherlands)
Nancy Y-Y. Ip (Kowloon, Hongkong)
Takeshi Iwatsubo (Bunkyo-Ku, Japan)
Valter D. Longo (Los Angeles, CA, USA)
Paula I. Moreira (Coimbra, Portugal)
Antonio Moschetta (Santa Maria Imbaro,
Italy)
Athanasios Papavassiliou (Athens, 
Greece)
Hemachandra Reddy (Beaverton, 
OR, USA)
Jacqueline M. Stephens (Baton Rouge, 
LA, USA)
Russell H. Swerdlow (Kansas City, 
KS, USA)
Ronald J.A. Wanders (Amsterdam, 
The Netherlands)
Patricia D. Wilson (London, UK)
Massimo Zeviani (Milano, Italy)
Zhouhua Zhang (Changsha, China)
Xiongwei Zhu (Cleveland, OH, 
USA)
Shawnna Buttery
Claudia Montefusco
Laura Wallins
Denise M. Wells (Manager)
Amsterdam  – Boston – London – New York – Oxford – Paris – 
Philadelphia – San Diego – St. Louis
Scientific Editors (Elsevier, Cambridge, MA, USA):
Keywords that indicate the expertise of each Editor can be found on the journal homepage at
http://www.elsevier.com/locate/bbadis
Publication information: Biochimica et Biophysica 
Acta (Molecular Basis of Disease) (ISSN 0925-4439). 
For 2013, Volume 1832 (12 issues) is scheduled for 
publication. Subscription prices are available upon 
request from the Publisher or from the Elsevier 
Customer Service Department nearest you, or from 
this journal’s website (http://www.elsevier.com/
locate/bbadis). Further information is available on 
this journal and other Elsevier products through 
Elsevier’s website (http://www.elsevier.com). 
Subscriptions are accepted on a prepaid basis 
only and are entered on a calendar year basis. 
Issues are sent by standard mail (surface within 
Europe, air delivery outside Europe). Priority rates 
are available upon request. Claims for missing 
issues should be made within six months of the 
date of dispatch. Orders, claims, and journal 
enquiries: please contact the Elsevier Customer 
Service Department nearest you: St. Louis: Elsevier 
Customer Service Department, 3251 Riverport 
Lane, Maryland Heights, MO 63043, USA; phone: 
(877) 8397126 [toll free within the USA];  (+1) 
(314) 4478878 [outside the USA]; fax: (+1) (314) 
4478077; e-mail: JournalCustomerService-usa@
elsevier.com Oxford: Elsevier Customer Service 
Department, The Boulevard, Langford Lane, 
Kidlington, Oxford OX5 1GB, UK; phone:  (+44) 
(1865) 843434; fax: (+44) (1865) 843970; e-mail: 
JournalsCustomerServiceEMEA@elsevier.com  
Tokyo: Elsevier Customer Service Department, 4F 
Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-
Azabu,  Minato-ku, Tokyo 106-0044, Japan; 
phone: (+81) (3) 5561 5037; fax: (+81) (3) 5561 
5047; e-mail: JournalsCustomerServiceJapan@
elsevier.com Singapore: Elsevier Customer 
Service Department, 3 Killiney Road, #08-01 
Winsland House I, Singapore 239519; phone: 
(+65) 63490222; fax: (+65) 67331510; e-mail: 
JournalsCustomerServiceAPAC@elsevier.com
Author enquiries: For enquiries relating to the 
submission of articles (including electronic 
submission) please visit this journal’s homepage 
at http://www.elsevier.com/locate/bbadis. 
For detailed instructions on the preparation 
of electronic artwork, please visit http://www.
elsevier.com/artworkinstructions. Contact details 
for questions arising after acceptance of an 
article, especially those relating to proofs, will 
be provided by the publisher. You can track 
accepted articles at http://www.elsevier.com/
trackarticle. You can also check our Author FAQs 
at http://www.elsevier.com/authorFAQ and/or 
contact Customer Support via http://support.
elsevier.com/.
Advertising information: If you are interested 
in advertising or other commercial opportunities
please e-mail Commercialsales@elsevier.com and 
your enquiry will be passed to the correct person
who will respond to you within 48 hours.
Printed by Polestar Wheatons Ltd., Exeter, 
United Kingdom
       The paper used in this publication meets the
     requirements of ANSI/NISO Z39.48-1992 
(Permanence of Paper)
Front cover image: Integrated view of SHP 
as a central transcriptional coregulator in diverse 
physiological pathways in the liver. Activation 
pathways are shown as broken blue arrows and 
inhibitory pathways are shown as broken red 
lines. FA, fatty acid; TG, triglyceride; VLDL, very 
low density lipoprotein; CYP7A1, cytochrome 
P450 enzyme cholesterol 7α-hydroxylase; G6P, 
glucose-6-phosphatase; HNF-4α, hepatocyte 
nuclear factor 4 α; JNK, c-jun N-terminal 
kinase; LRH-1, liver receptor homolog-1; LXR, 
liver X receptor; MTP, microsomal triglyceride 
transfer protein; PEPCK, phosphoenolpyruvate 
carboxykinase; PPARγ, peroxisome proliferator-
activated receptor γ; SHP, small heterodimer 
partner; SREBP-1c, sterol regulatory element-
binding protein-1c; WAT, white adipose tissue; 
and BAT, brown adipose tissue. See Zhang et al., 
Volume 1812, Issue 8, Pages 893-908.
